The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms
Age: 18 years - 66+
Gender: All
We've found 3 total result s for "Carcinoma Neuroendocrine".
This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial cancer (EC); head and neck squamous cell carcinoma (HNSCC); pancreatic ductal adenocarcinoma (PDAC); colorectal cancer (CRC); hepatocel...
- Recurrence
- Endometrial Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Colorectal Neoplasms
- Carcinoma, Hepatocellular
- Adenocarcinoma Of Esophagus
- Carcinoma, Transitional Cell
- Ovarian Neoplasms
- Uterine Cervical Neoplasms
- Biliary Tract Neoplasms
- Melanoma
- Carcinoma, Neuroendocrine
Age: 18 years - 66+
Gender: All
The Personalized Discovery Process is the only program offering patients treatment recommendations based on an empirically constructed Drosophila "fly" model of their disease. Special committee selects one of the one of the few 2-3 FDA approved drug combinations or sing...
Age: 18 years - 66+
Gender: All